SIG Members and Expertise Pediatric SIG Website Information - Membership Contact Region Name Affiliation Email Major Area(s) of Interest SIG Liaison School of Pharmacy, National Cheng Kung University, Tainan, psychiatry, neurology, pediatrics, geriatrics, ASIA/AUSTRALIA Edward Chia-Cheng Lai [email protected] AsPEN Taiwan international pharmacoepidemiologic study paediatrician, clinical pharmacology & therapeutics, clinical epidemiology & health Madlen Gazarian, MD University of NSW, Sydney [email protected] services research, pharmacoepidemiology & pharmacovigilance infectious disease epidemiology, Wan-Ting Huang Taiwan Centers for Disease Control [email protected]; [email protected] pharmacoepidemiology, pediatrics, vaccines AFRICA Ibrahim Oreagba University of Lagos, Nigeria [email protected] pharmacovigilance, clinical pharmacology EUROPE Esme Baan Erasmus University, Rotterdam [email protected] asthma therapy in children Veronique De Smet Clinical Pharmacist [email protected] off label medication, pediatric formularies Genevieve Durriieu Clinical Pharmacologist, University of Toulouse France [email protected] drug safety, off label drug use Florentia Kaguelidou, MD, PhD Paris Diderot Unversity-APHP [email protected] pharmacoepidemiology, drug utilization pharmacoepidemiology, pediatrics, vaccines, Andrea Margulis MD ScD RTI Health Solutions [email protected]; [email protected] drug safety in pregnancy Miriam Sturkenboon University Medical Center, Utrecht [email protected] methods, pediatric databases, vaccines Vaccine, Database Osemeke Osokogu Erasmus Medical Center [email protected] methods exposures, outcomes NORTH AMERICA AlArtaman,MDPhDMHA University of Manitoba College of Medicine [email protected] cancer, perinatal, global health epidemiology Oncology Paul Bakaki Case Western Reserve University [email protected] polypharmacy drug safety and outcomes research, causal Mehmet Burcu, PhD, MS Merck Co., Inc [email protected] inference, health policy, drug utilization, psychiatry, and cancer psychotropic medications, pediatrics, Greta Bushnell, MSPH University of North Carolina at Chapel Hill [email protected] Adherence pharmacoepidemiology comparative effectiveness, multimorbidity, Wendy Camelo Castillo, MD MSc PhD University of Maryland, Baltimore [email protected] mental health, medications in pregnancy pharmacoepidemiology, pharmacogenomics, Bruce Carleton PharmD University of British Columbia Faculty of Medicine [email protected] complex diseases psychotropic outcomes; multi-morbidity, foster Susan dosReis, PhD University of Maryland School of Pharmacy [email protected] care and vulnerable populations polypharmacy, drug-drug interactions, complex James Feinstein MD MPH University of Colorado School of Medicine [email protected] chronic diseases, epidermolysis bullosa glucocorticoids, antibiotics, pediatric Daniel B. Horton MD MSCE Rutgers University [email protected] rheumatology, juvenile idiopathic arthritis clinical trial methodology, systematic reviews, Lauren Kelley, PhD, CCRP University of Manitoba [email protected] opioids, neonatal drug development antibiotic utilization and stewardship, Alan Kinlaw, PhD University of North Carolina at Chapel Hill [email protected] respiratory diseases, vaccines, causal inference pain medications, antibiotics, drug utilization, Tamar Lasky, PhD, FISPE MIE Resources [email protected] real world evidence, policy, vaccines drug policy research, clinical pharmacology, Stuart MacLeod, MD, PhD University of British Columbia [email protected] global child health SIG Members and Expertise Pediatric SIG Website Information - Membership Contact Region Name Affiliation Email Major Area(s) of Interest SIG Liaison pediatric pharmacoepidemiology, pediatric drug NORTH AMERICA , Ann W. McMahon, MD, MS Food and Drug Administration, Silver Spring, Maryland ann.mcmahon@ fda.hhs.gov safety, pediatric post-marketing safety Continued surveillance. pediatric postmarketing databases pharmacoepidemiology; pediatric mental health; Dinci Pennap, MPH University of Maryland School of Pharmacy [email protected] psychotropic medication utilzation and health disparities Sudha Raman Duke University [email protected] neonatal pharmacoepidemiology, neonatal Jonathan Slaughter, MD MPH Nationwide Children's Hospital/The Ohio State University [email protected] outcomes research, neonatal comparative effectiveness research pharmacoepidemiology; psychotropic utilization; O'Mareen Spence, MPH University of Maryland School of Pharmacy [email protected] pediatrics; pediatric pharmacoepidemiology, pediatric drug safety, pediatric post-marketing safety Rachel E. Sobel, DrPH Pfizer Inc [email protected] BRACE surveillance, pediatric registries, public-private partnerships. pharmacoepidemiology; vaccines; medicines in Lina Titievsky, PhD MPH Epidemiology, Worldwide Safety and Strategy, Pfizer Inc [email protected] pregnancy; impact of in utero exposures on Vaccines adult health; study design/methods Geert tJong, MD, PhD University of Maitoba [email protected] clinical pharmacology, pharmacoepidemiology drug utilization, drug safety, mental health, Julie M. Zito, PhD, FISPE University of Maryland, Baltimore [email protected] psychotropic medications, and health policy.